Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - PA: Human Development, Child and Youth Health

McGill University

$100,000.00

Non-canonical signaling by NMDA receptors in the Fragile X brain

FY 2021-22

Summary
Fragile-X syndrome (FXS) is a neurodevelopmental disorder that is the most common single- gene cause of autism and inherited intellectual disability. In Canada, it affects 1 in 4,000 boys and 1 in 6,000 girls irrespective of race or ethnic background. FXS results from disrupted expression of the Fragile X mental retardation protein (FMRP), a RNA binding protein essential for normal brain development. Despite this level of understanding, there is still no cure or specific treatment for FXS. Consequently, any future advances will rely on a better understanding of how the absence of FMRP leads to deficits in the FXS brain. In this grant application, we identify a homeostatic regulatory mechanism that couples the activity of nerve cells with local blood flow in a brain region called the cerebellum. We propose that this homeostatic mechanism is not unique to the cerebellum but found throughout the brain where it maintains the balance between excitatory and inhibitory (E/I) signaling. Importantly, the coupling between neuronal activity and cerebral blood flow is lost in a mouse model of FXS but can be rescued with a small molecule that boosts the deficits in the signaling pathway. The benefit of the proposed project is that it aims to uncover the widespread occurrence of a potentially important defect in FXS that can be corrected by pharmacological treatment.
Program
Project Grant - PA: Human Development, Child and Youth Health
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
464946
Name
Bowie Derek
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Molecular & Cellular Neurosciences - B
Projecttitle
Non-canonical signaling by NMDA receptors in the Fragile X brain
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Human Development, Child and Youth Health
Keyworddelim
Cerebellum; Electrophysiology; Fragile X Syndrome; Gaba-A Receptor; Neuronal Nitric Oxide Synthase; Nmda Receptor
Abstract
Fragile-X syndrome (FXS) is a neurodevelopmental disorder that is the most common single- gene cause of autism and inherited intellectual disability. In Canada, it affects 1 in 4,000 boys and 1 in 6,000 girls irrespective of race or ethnic background. FXS results from disrupted expression of the Fragile X mental retardation protein (FMRP), a RNA binding protein essential for normal brain development. Despite this level of understanding, there is still no cure or specific treatment for FXS. Consequently, any future advances will rely on a better understanding of how the absence of FMRP leads to deficits in the FXS brain. In this grant application, we identify a homeostatic regulatory mechanism that couples the activity of nerve cells with local blood flow in a brain region called the cerebellum. We propose that this homeostatic mechanism is not unique to the cerebellum but found throughout the brain where it maintains the balance between excitatory and inhibitory (E/I) signaling. Importantly, the coupling between neuronal activity and cerebral blood flow is lost in a mouse model of FXS but can be rescued with a small molecule that boosts the deficits in the signaling pathway. The benefit of the proposed project is that it aims to uncover the widespread occurrence of a potentially important defect in FXS that can be corrected by pharmacological treatment.
Competitiondate
202203
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bowie, Derek
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~